Journal of Pharmacology and Experimental Therapeutics

Journal Abbreviation: J PHARMACOL EXP THER
ISSN: 0022-3565
Publisher: American Society for Pharmacology and Experimental Therapeutics (ASPET)

Publications (8)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Prenatal treatment of X-linked hypohidrotic ectodermal dysplasia using recombinant ectodysplasin in a canine model (2019) Margolis CA, Schneider P, Huttner K, Kirby N, Houser TP, Wildman L, Grove GL, et al. Journal article Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels (2016) Schillers F, Eberhardt E, Leffler A, Eberhardt M Journal article Pharmacological Profile of 2-Bromoterguride at Human Dopamine D2, Porcine Serotonin 5-HT2A and α2C-Adrenergic Receptors, and its Antipsychotic-Like Effects in Rats (2013) Jantschak F, Brosda J, Franke RT, Fink H, Möller D, Hübner H, Gmeiner P, Pertz HH Journal article Pharmacological profile of 2-bromoterguride at human dopamine D 2, porcine serotonin 5-hydroxytryptamine 2A, and α 2C-adrenergic receptors, and its antipsychotic-like effects in rats (2013) Jantschak F, Brosda J, Franke RT, Fink H, Möller D, Hübner H, Gmeiner P, Pertz HH Journal article, Original article The bulky N(6) substituent of cabergoline is responsible for agonism of this drug at serotonin 5-HT2a and 5-HT2b receptors and thus a determinant of valvular heart disease (2011) Kekewska A, Hübner H, Gmeiner P, Pertz HH Journal article The bulky N(6) substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine (5-HT)2A and 5-HT2B receptors and thus is a determinant of valvular heart disease (2011) Kekewska A, Hübner H, Gmeiner P, Pertz HH Journal article, Original article Characterization of the Molecular Fragment that is Responsible for Agonism of Pergolide at Serotonin 5-HT2B and 5-HT2A Receptors (2008) Goernemann T, Hübner H, Gmeiner P, Horowski R, Latte KP, Flieger M, Pertz HH Journal article Neurokinin-1 Receptor Antagonists Protect Mice from CD95- and Tumor Necrosis Factor-α-Mediated Apoptotic Liver Damage (2004) Bang R, Biburger M, Neuhuber W, Tiegs G Journal article, Original article